DK0705273T3 - 17-Halogen-4-azaandrostenderivater og fremgangsmåde til fremstilling af sådanne - Google Patents

17-Halogen-4-azaandrostenderivater og fremgangsmåde til fremstilling af sådanne

Info

Publication number
DK0705273T3
DK0705273T3 DK93913460T DK93913460T DK0705273T3 DK 0705273 T3 DK0705273 T3 DK 0705273T3 DK 93913460 T DK93913460 T DK 93913460T DK 93913460 T DK93913460 T DK 93913460T DK 0705273 T3 DK0705273 T3 DK 0705273T3
Authority
DK
Denmark
Prior art keywords
pct
azaandrosten
halogen
derivatives
preparation
Prior art date
Application number
DK93913460T
Other languages
Danish (da)
English (en)
Inventor
Zoltan Tuba
Judit Horvath
Marsai Maria Lovasne
Gabor Balogh
Janos Szeles
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Application granted granted Critical
Publication of DK0705273T3 publication Critical patent/DK0705273T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK93913460T 1993-06-24 1993-06-24 17-Halogen-4-azaandrostenderivater og fremgangsmåde til fremstilling af sådanne DK0705273T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/HU1993/000040 WO1995000532A1 (en) 1993-06-24 1993-06-24 17-halogeno-4-azaandrostene derivatives and process for the preparation thereof

Publications (1)

Publication Number Publication Date
DK0705273T3 true DK0705273T3 (da) 2002-06-17

Family

ID=10982848

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93913460T DK0705273T3 (da) 1993-06-24 1993-06-24 17-Halogen-4-azaandrostenderivater og fremgangsmåde til fremstilling af sådanne

Country Status (15)

Country Link
US (1) US5583228A (de)
EP (1) EP0705273B1 (de)
JP (1) JP3300359B2 (de)
KR (1) KR100255679B1 (de)
AT (1) ATE215093T1 (de)
AU (1) AU680825B2 (de)
CA (1) CA2166089C (de)
DE (1) DE69331764T2 (de)
DK (1) DK0705273T3 (de)
ES (1) ES2173890T3 (de)
FI (1) FI956235A0 (de)
PT (1) PT705273E (de)
RU (1) RU2103275C1 (de)
UA (1) UA41934C2 (de)
WO (1) WO1995000532A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU212459B (en) * 1992-10-02 1996-06-28 Richter Gedeon Vegyeszet Process for producing new 17-beta-substituted 4-aza-androstane-derivatives and pharmaceutical compositions containing them
CA2524409C (en) * 2003-05-07 2011-12-20 Merck & Co., Inc. Androgen receptor modulators and methods of use thereof
CN102603839A (zh) * 2012-01-13 2012-07-25 宜城市共同药业有限公司 去氢表雄酮的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US5359071A (en) * 1993-03-12 1994-10-25 Merck & Co., Inc. 15-substituted 4-azasteroids

Also Published As

Publication number Publication date
AU4352793A (en) 1995-01-17
ATE215093T1 (de) 2002-04-15
AU680825B2 (en) 1997-08-14
DE69331764D1 (de) 2002-05-02
DE69331764T2 (de) 2002-10-02
EP0705273B1 (de) 2002-03-27
JPH08511797A (ja) 1996-12-10
EP0705273A1 (de) 1996-04-10
PT705273E (pt) 2002-07-31
UA41934C2 (uk) 2001-10-15
ES2173890T3 (es) 2002-11-01
FI956235A (fi) 1995-12-22
CA2166089A1 (en) 1995-01-05
FI956235A0 (fi) 1995-12-22
US5583228A (en) 1996-12-10
JP3300359B2 (ja) 2002-07-08
WO1995000532A1 (en) 1995-01-05
RU2103275C1 (ru) 1998-01-27
KR100255679B1 (ko) 2000-08-01
CA2166089C (en) 2004-01-27
KR960703134A (ko) 1996-06-19

Similar Documents

Publication Publication Date Title
AU7116691A (en) Process for the preparation of oxetanones
DK0712396T3 (da) Substituerede azadioxacycloalkener og deres anvendelse som fungicider
DK0730581T3 (da) 3-acylaminobezazepiner
DK0787124T3 (da) Fremgangsmåde til fremstilling af substituerede 3-aminobenzonitriler
DK1404642T3 (da) Fremgangsmåde til fremstillimg af 7-amino-syn-3,5-dihydroxyheptansyrederivater, mellemprodukter derfor og fremgangsmåder til deres fremstilling
DK0749438T3 (da) Hidtil ukendte silylforbindelser og deres anvendelse
DK0705273T3 (da) 17-Halogen-4-azaandrostenderivater og fremgangsmåde til fremstilling af sådanne
DK0873327T3 (da) Fremgangsmåde til fremstilling af 2-chlor-5-chlormethyl-thiazol
NO923226L (no) Nytt beta-fenylisoserinderivat, dets fremstilling og anvendelse
DK1104409T3 (da) Fremgangsmåde til fremstilling af piperazinsyre og omdannelse deraf til N-acylerede bicykliske ringe, der indeholder N,N-bindinger, hvilke forbindelser er nyttige som mellemprodukter for caspaseinhibitorer
GR3029590T3 (en) Crystalline, polymorphic form of (s,s,s)-n-(1- 2-carboxy-3-(n?2 -mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine
TW288005B (de)
DK0691986T3 (da) Hidtil ukendte fremgangsmåder og mellemproduktforbindelser til fremstillingen af blodpladeglycoprotein IIb/IIIa-inhibitorer